HSV-2 immediate-early protein US1 inhibits IFN-β production by suppressing association of IRF-3 with IFN-β promoter

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3102-3115

  Zhang, Mudan ^a,b   Liu, Yalan ^a   Wang, Ping ^a,b   Guan, Xinmeng ^a,b   He, Siyi ^a,b   Luo, Sukun ^a,b   Li, Chang ^a,b   Hu, Kai ^a   Jin, Wei ^a,b   Du, Tao ^a   Yan, Yan ^a,b   Zhang, Zhenfeng ^a   Zheng, Zhenhua ^a   Wang, Hanzhong ^a   Hu, Qinxue ^a,c  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; PROTEIN US1; UNCLASSIFIED DRUG; VIRUS PROTEIN; IMMEDIATE EARLY PROTEIN; PROTEIN BINDING; US1 PROTEIN, HUMAN HERPESVIRUS 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DOWN REGULATION; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SENDAI VIRUS; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PROMOTER REGION;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; HERPESVIRUS 2, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; SIGNAL TRANSDUCTION;

EID: 84925856835     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401538     Document Type: Article

References (102)

1. Sørensen, L. N., L. S. Reinert, L. Malmgaard, C. Bartholdy, A. R. Thomsen, and S. R. Paludan. 2008. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J. Immunol. 181: 8604-8612.
2. Mazumder, B., D. Poddar, A. Basu, R. Kour, V. Verbovetskaya, and S. Barik. 2014. Extraribosomal l13a is a specific innate immune factor for antiviral defense. J. Virol. 88: 9100-9110.
3. Green, A. M., P. R. Beatty, A. Hadjilaou, and E. Harris. 2014. Innate immunity to dengue virus infection and subversion of antiviral responses. J. Mol. Biol. 426: 1148-1160.
4. Haller, O., G. Kochs, and F. Weber. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344: 119-130.
5. Pichlmair, A., and C. Reis e Sousa. 2007. Innate recognition of viruses. Immunity 27: 370-383.
6. Desmet, C. J., and K. J. Ishii. 2012. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat. Rev. Immunol. 12: 479-491.
7. Paludan, S. R., A. G. Bowie, K. A. Horan, and K. A. Fitzgerald. 2011. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11: 143-154.
8. Iwasaki, A., and R. Medzhitov. 2010. Regulation of adaptive immunity by the innate immune system. Science 327: 291-295.
9. Kawai, T., and S. Akira. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143: 1-20.
10. Hiscott, J., P. Pitha, P. Genin, H. Nguyen, C. Heylbroeck, Y. Mamane, M. Algarte, and R. Lin. 1999. Triggering the interferon response: the role of IRF-3 transcription factor. J. Interferon Cytokine Res. 19: 1-13.
11. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
12. Lin, R., Y. Mamane, and J. Hiscott. 1999. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol. Cell. Biol. 19: 2465-2474.
13. Melroe, G. T., N. A. DeLuca, and D. M. Knipe. 2004. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J. Virol. 78: 8411-8420.
14. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496.
15. Talon, J., C. M. Horvath, R. Polley, C. F. Basler, T. Muster, P. Palese, and A. García-Sastre. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74: 7989-7996.
16. Suhara, W., M. Yoneyama, I. Kitabayashi, and T. Fujita. 2002. Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex. J. Biol. Chem. 277: 22304-22313.
17. Ronco, L. V., A. Y. Karpova, M. Vidal, and P. M. Howley. 1998. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12: 2061-2072.
18. Graff, J. W., D. N. Mitzel, C. M. Weisend, M. L. Flenniken, and M. E. Hardy. 2002. Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. J. Virol. 76: 9545-9550.
19. Burýsek, L., W. S. Yeow, B. Lubyová, M. Kellum, S. L. Schafer, Y. Q. Huang, and P. M. Pitha. 1999. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol. 73: 7334-7342.
20. Juang, Y.-T., W. Lowther, M. Kellum, W. C. Au, R. Lin, J. Hiscott, and P. M. Pitha. 1998. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95: 9837-9842.
21. Chakravarti, D., V. Ogryzko, H. Y. Kao, A. Nash, H. Chen, Y. Nakatani, and R. M. Evans. 1999. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96: 393-403.
22. Zhu, H., C. Zheng, J. Xing, S. Wang, S. Li, R. Lin, and K. L. Mossman. 2011. Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3. J. Virol. 85: 11079-11089.
23. Saira, K., Y. Zhou, and C. Jones. 2007. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity. J. Virol. 81: 3077-3086.
24. Basler, C. F., A. Mikulasova, L. Martinez-Sobrido, J. Paragas, E. Mühlberger, M. Bray, H. D. Klenk, P. Palese, and A. García-Sastre. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77: 7945-7956.
25. Sagong, M., and C. Lee. 2011. Porcine reproductive and respiratory syndrome virus nucleocapsid protein modulates interferon-β production by inhibiting IRF3 activation in immortalized porcine alveolar macrophages. Arch. Virol. 156: 2187-2195.
26. Sen, N., M. Sommer, X. Che, K. White, W. T. Ruyechan, and A. M. Arvin. 2010. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. J. Virol. 84: 9240-9253.
27. Unterholzner, L., R. P. Sumner, M. Baran, H. Ren, D. S. Mansur, N. M. Bourke, F. Randow, G. L. Smith, and A. G. Bowie. 2011. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog. 7: e1002247.
28. Beura, L. K., S. N. Sarkar, B. Kwon, S. Subramaniam, C. Jones, A. K. Pattnaik, and F. A. Osorio. 2010. Porcine reproductive and respiratory syndrome virus nonstructural protein 1β modulates host innate immune response by antagonizing IRF3 activation. J. Virol. 84: 1574-1584.
29. Foy, E., K. Li, C. Wang, R. Sumpter, Jr., M. Ikeda, S. M. Lemon, and M. Gale, Jr. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300: 1145-1148.
30. Li, H., Z. Zheng, P. Zhou, B. Zhang, Z. Shi, Q. Hu, and H. Wang. 2010. The cysteine protease domain of porcine reproductive and respiratory syndrome virus non-structural protein 2 antagonizes interferon regulatory factor 3 activation. J. Gen. Virol. 91: 2947-2958.
31. Cloutier, N., and L. Flamand. 2010. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter. J. Biol. Chem. 285: 7208-7221.
32. Zhang, Z., Z. Zheng, H. Luo, J. Meng, H. Li, Q. Li, X. Zhang, X. Ke, B. Bai, P. Mao, et al. 2012. Human bocavirus NP1 inhibits IFN-β production by blocking association of IFN regulatory factor 3 with IFNB promoter. J. Immunol. 189: 1144-1153.
33. Shukla, D., and P. G. Spear. 2001. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108: 503-510.
34. Martinelli, E., H. Tharinger, I. Frank, J. Arthos, M. Piatak, Jr., J. D. Lifson, J. Blanchard, A. Gettie, and M. Robbiani. 2011. HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog. 7: e1002109.
35. Wang, K., J. D. Kappel, C. Canders, W. F. Davila, D. Sayre, M. Chavez, L. Pesnicak, and J. I. Cohen. 2012. A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM. J. Virol. 86: 12891-12902.
36. Vahlne, A., B. Svennerholm, M. Sandberg, A. Hamberger, and E. Lycke. 1980. Differences in attachment between herpes simplex type 1 and type 2 viruses to neurons and glial cells. Infect. Immun. 28: 675-680.
37. Gupta, A., P. K. Rani, B. Bagga, P. Dore, A. Mittal, and S. Jalali. 2010. Bilateral herpes simplex-2 acute retinal necrosis with encephalitis in premature twins. J. AAPOS 14: 541-543.
38. Miller, S., F. J. Mateen, and A. J. Aksamit, Jr. 2013. Herpes simplex virus 2 meningitis: a retrospective cohort study. J. Neurovirol. 19: 166-171.
39. Margolis, T. P., Y. Imai, L. Yang, V. Vallas, and P. R. Krause. 2007. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J. Virol. 81: 1872-1878.
40. Akhtar, J., and D. Shukla. 2009. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J. 276: 7228-7236.
41. Ma, Y., and B. He. 2014. Recognition of herpes simplex viruses: toll-like receptors and beyond. J. Mol. Biol. 426: 1133-1147.
42. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198: 513-520.
43. Liu, H., K. Chen, W. Feng, X. Wu, and H. Li. 2013. TLR4-MyD88/Mal-NF-kB axis is involved in infection of HSV-2 in human cervical epithelial cells. PLoS ONE 8: e80327.
44. Triantafilou, K., D. Eryilmazlar, and M. Triantafilou. 2014. Herpes simplex virus 2-induced activation in vaginal cells involves Toll-like receptors 2 and 9 and DNA sensors DAI and IFI16. Am. J. Obstet. Gynecol. 210: 122 e1-122 e10.
45. Cai, M., M. Li, K. Wang, S. Wang, Q. Lu, J. Yan, K. L. Mossman, R. Lin, and C. Zheng. 2013. The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway. PLoS ONE 8: e54586.
46. Leoni, V., T. Gianni, S. Salvioli, and G. Campadelli-Fiume. 2012. Herpes simplex virus glycoproteins gH/gL and gB bind Toll-like receptor 2, and soluble gH/gL is sufficient to activate NF-κB. J. Virol. 86: 6555-6562.
47. Liu, X., K. Fitzgerald, E. Kurt-Jones, R. Finberg, and D. M. Knipe. 2008. Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein. Proc. Natl. Acad. Sci. USA 105: 11335-11339.
48. Peng, T., J. Zhu, A. Klock, K. Phasouk, M. L. Huang, D. M. Koelle, A. Wald, and L. Corey. 2009. Evasion of the mucosal innate immune system by herpes simplex virus type 2. J. Virol. 83: 12559-12568.
49. Lieber, D., and S. M. Bailer. 2013. Determination of HSV-1 infectivity by plaque assay and a luciferase reporter cell line. Methods Mol. Biol. 1064: 171-181.
50. Killian, M. L. 2008. Hemagglutination assay for the avian influenza virus. Methods Mol. Biol. 436: 47-52.
51. Sharan, S. K., L. C. Thomason, S. G. Kuznetsov, and D. L. Court. 2009. Recombineering: a homologous recombination-based method of genetic engineering. Nat. Protoc. 4: 206-223.
52. Chang, T. H., C. L. Liao, and Y. L. Lin. 2006. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect. 8: 157-171.
53. Ehrhardt, C., C. Kardinal, W. J. Wurzer, T. Wolff, C. von Eichel-Streiber, S. Pleschka, O. Planz, and S. Ludwig. 2004. Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett. 567: 230-238.
54. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737.
55. Huang, W., K. Hu, S. Luo, M. Zhang, C. Li, W. Jin, Y. Liu, G. E. Griffin, R. J. Shattock, and Q. Hu. 2012. Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4+ T cell migration via activation of p38-CCAAT/enhancer-binding protein-β pathway. J. Immunol. 188: 6247-6257.
56. Kallfass, C., A. Ackerman, S. Lienenklaus, S. Weiss, B. Heimrich, and P. Staeheli. 2012. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J. Virol. 86: 11223-11230.
57. Kadeppagari, R. K., R. L. Sanchez, and T. P. Foster. 2012. HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanisms. Virus Res. 167: 273-284.
58. Lilley, C. E., F. Groutsi, Z. Han, J. A. Palmer, P. N. Anderson, D. S. Latchman, and R. S. Coffin. 2001. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J. Virol. 75: 4343-4356.
59. Dolan, A., F. E. Jamieson, C. Cunningham, B. C. Barnett, and D. J. McGeoch. 1998. The genome sequence of herpes simplex virus type 2. J. Virol. 72: 2010-2021.
60. Honess, R. W., and B. Roizman. 1974. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14: 8-19.
61. Honess, R. W., and B. Roizman. 1975. Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc. Natl. Acad. Sci. USA 72: 1276-1280.
62. Hale, B. G., R. E. Randall, J. Ortín, and D. Jackson. 2008. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89: 2359-2376.
63. Bowman, J. J., and P. A. Schaffer. 2009. Origin of expression of the herpes simplex virus type 1 protein U(S)1.5. J. Virol. 83: 9183-9194.
64. O'Toole, J. M., M. Aubert, A. Kotsakis, and J. A. Blaho. 2003. Mutation of the protein tyrosine kinase consensus site in the herpes simplex virus 1 α22 gene alters ICP22 posttranslational modification. Virology 305: 153-167.
65. Orzalli, M. H., N. A. DeLuca, and D. M. Knipe. 2012. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc. Natl. Acad. Sci. USA 109: E3008-E3017.
66. Melroe, G. T., L. Silva, P. A. Schaffer, and D. M. Knipe. 2007. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology 360: 305-321.
67. Johnson, K. E., and D. M. Knipe. 2010. Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation. Virology 396: 21-29.
68. Johnson, K. E., B. Song, and D. M. Knipe. 2008. Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling. Virology 374: 487-494.
69. Jaworska, J., A. Gravel, K. Fink, N. Grandvaux, and L. Flamand. 2007. Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein. J. Virol. 81: 5737-5748.
70. Kochs, G., A. García-Sastre, and L. Martínez-Sobrido. 2007. Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 81: 7011-7021.
71. Paladino, P., S. E. Collins, and K. L. Mossman. 2010. Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS ONE 5: e10428.
72. Lin, R., P. Genin, Y. Mamane, M. Sgarbanti, A. Battistini, W. J. Harrington, Jr., G. N. Barber, and J. Hiscott. 2001. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20: 800-811.
73. Servant, M. J., N. Grandvaux, B. R. tenOever, D. Duguay, R. Lin, and J. Hiscott. 2003. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278: 9441-9447.
74. Centers for Disease Control and Prevention. 2010. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 Years-United States, 2005-2008 (Reprinted from MMWR, vol 59, pg 456-459, 2010). JAMA 304: 849-850.
75. Ohashi, M., A. S. Bertke, A. Patel, and P. R. Krause. 2011. Spread of herpes simplex virus to the spinal cord is independent of spread to dorsal root ganglia. J. Virol. 85: 3030-3032.
76. Xing, J., S. Wang, R. Lin, K. L. Mossman, and C. Zheng. 2012. Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5. J. Virol. 86: 3528-3540.
77. van Lint, A. L., M. R. Murawski, R. E. Goodbody, M. Severa, K. A. Fitzgerald, R. W. Finberg, D. M. Knipe, and E. A. Kurt-Jones. 2010. Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J. Virol. 84: 10802-10811.
78. Melchjorsen, J., J. Sirén, I. Julkunen, S. R. Paludan, and S. Matikainen. 2006. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J. Gen. Virol. 87: 1099-1108.
79. Xing, J., L. Ni, S. Wang, K. Wang, R. Lin, and C. Zheng. 2013. Herpes simplex virus 1-encoded tegument protein VP16 abrogates the production of beta interferon (IFN) by inhibiting NF-κB activation and blocking IFN regulatory factor 3 to recruit its coactivator CBP. J. Virol. 87: 9788-9801.
80. Wang, S., K. Wang, R. Lin, and C. Zheng. 2013. Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production. J. Virol. 87: 12814-12827.
81. Duerst, R. J., and L. A. Morrison. 2004. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology 322: 158-167.
82. Yao, X. D., and K. L. Rosenthal. 2011. Herpes simplex virus type 2 virion host shutoff protein suppresses innate dsRNA antiviral pathways in human vaginal epithelial cells. J. Gen. Virol. 92: 1981-1993.
83. Asai, R., T. Ohno, A. Kato, and Y. Kawaguchi. 2007. Identification of proteins directly phosphorylated by UL13 protein kinase from herpes simplex virus 1. Microbes Infect. 9: 1434-1438.
84. Bastian, T. W., C. M. Livingston, S. K. Weller, and S. A. Rice. 2010. Herpes simplex virus type 1 immediate-early protein ICP22 is required for VICE domain formation during productive viral infection. J. Virol. 84: 2384-2394.
85. Bastian, T. W., and S. A. Rice. 2009. Identification of sequences in herpes simplex virus type 1 ICP22 that influence RNA polymerase II modification and viral late gene expression. J. Virol. 83: 128-139.
86. Cun, W., J. Chen, Y. Zhang, L. D. Liu, and Q. H. Li. 2010. Analysis of the cellular localization of herpes simplex virus 1 immediate-early protein ICP22. Virol. Sin. 25: 158-167.
87. Fraser, K. A., and S. A. Rice. 2007. Herpes simplex virus immediate-early protein ICP22 triggers loss of serine 2-phosphorylated RNA polymerase II. J. Virol. 81: 5091-5101.
88. Long, M. C., V. Leong, P. A. Schaffer, C. A. Spencer, and S. A. Rice. 1999. ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J. Virol. 73: 5593-5604.
89. Rice, S. A., M. C. Long, V. Lam, P. A. Schaffer, and C. A. Spencer. 1995. Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J. Virol. 69: 5550-5559.
90. Guo, L., W. J. Wu, L. D. Liu, L. C. Wang, Y. Zhang, L. Q. Wu, Y. Guan, and Q. H. Li. 2012. Herpes simplex virus 1 ICP22 inhibits the transcription of viral gene promoters by binding to and blocking the recruitment of P-TEFb. PLoS ONE 7: e45749.
91. Mostafa, H. H., and D. J. Davido. 2013. Herpes simplex virus 1 ICP22 but not US 1.5 is required for efficient acute replication in mice and VICE domain formation. J. Virol. 87: 13510-13519.
92. Purves, F. C., W. O. Ogle, and B. Roizman. 1993. Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. USA 90: 6701-6705.
93. Mitchell, C., J. A. Blaho, and B. Roizman. 1994. Casein kinase II specifically nucleotidylylates in vitro the amino acid sequence of the protein encoded by the alpha 22 gene of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 91: 11864-11868.
94. Blaho, J. A., C. Mitchell, and B. Roizman. 1993. Guanylylation and adenylylation of the alpha regulatory proteins of herpes simplex virus require a viral beta or gamma function. J. Virol. 67: 3891-3900.
95. Purves, F. C., and B. Roizman. 1992. The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein α 22. Proc. Natl. Acad. Sci. USA 89: 7310-7314.
96. Cotter, C. R., M. L. Nguyen, J. S. Yount, C. B. López, J. A. Blaho, and T. M. Moran. 2010. The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells. PLoS ONE 5: e8684.
97. Cotter, C. R., W. K. Kim, M. L. Nguyen, J. S. Yount, C. B. López, J. A. Blaho, and T. M. Moran. 2011. The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling. J. Virol. 85: 12662-12672.
98. Lazear, H. M., A. Lancaster, C. Wilkins, M. S. Suthar, A. Huang, S. C. Vick, L. Clepper, L. Thackray, M. M. Brassil, H. W. Virgin, et al. 2013. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 9: e1003118.
99. Thackray, L. B., E. Duan, H. M. Lazear, A. Kambal, R. D. Schreiber, M. S. Diamond, and H. W. Virgin. 2012. Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication. J. Virol. 86: 13515-13523.
100. Inoue, K., K. Tsukiyama-Kohara, C. Matsuda, M. Yoneyama, T. Fujita, S. Kuge, M. Yoshiba, and M. Kohara. 2012. Impairment of interferon regulatory factor-3 activation by hepatitis C virus core protein basic amino acid region 1. Biochem. Biophys. Res. Commun. 428: 494-499.
101. Wang, Q., D. R. Nagarkar, E. R. Bowman, D. Schneider, B. Gosangi, J. Lei, Y. Zhao, C. L. McHenry, R. V. Burgens, D. J. Miller, et al. 2009. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 183: 6989-6997.
102. Ohman, T., J. Rintahaka, N. Kalkkinen, S. Matikainen, and T. A. Nyman. 2009. Actin and RIG-I/MAVS signaling components translocate to mitochondria upon influenza A virus infection of human primary macrophages. J. Immunol. 182: 5682-5692.